CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Trends Analyst Outlook Journalist POV

41 hedge funds and large institutions have $350M invested in Centessa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

48% less capital invested

Capital invested by funds: $669M → $350M (-$319M)

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$25M
2
+$2.13M
3
+$2.1M
4
Franklin Resources
Franklin Resources
California
+$1.05M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$846K

Top Sellers

1
-$32.1M
2
-$10.7M
3
-$9.45M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.52M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$287K
27
$281K
28
$272K
29
$196K
30
$192K
31
$81K
32
$50K
33
$29K
34
$8K
35
$7K
36
$6K
37
$5K
38
$3K
39
$2K
40
$1K
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2